1. Home
  2. VSTS vs CTMX Comparison

VSTS vs CTMX Comparison

Compare VSTS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$9.48

Market Cap

1.0B

Sector

N/A

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.89

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
CTMX
Founded
1936
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
977.1M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
VSTS
CTMX
Price
$9.48
$4.89
Analyst Decision
Sell
Strong Buy
Analyst Count
4
10
Target Price
$5.88
$12.10
AVG Volume (30 Days)
979.3K
6.9M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,734,839,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.67
$18.75
P/E Ratio
N/A
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$3.98
$0.63
52 Week High
$9.80
$8.21

Technical Indicators

Market Signals
Indicator
VSTS
CTMX
Relative Strength Index (RSI) 78.30 55.54
Support Level $7.24 $3.94
Resistance Level $9.80 $6.20
Average True Range (ATR) 0.32 0.28
MACD 0.17 0.07
Stochastic Oscillator 94.57 84.95

Price Performance

Historical Comparison
VSTS
CTMX

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: